Millions of people around the world die from heart failure every year. In future, a laboratory-grown heart patch could help with severe cases of cardiovascular disease, say scientists behind a ...

Nutrition, Prevention & Health found that Vitamin D is the most common deficiency which affects over 60 per cent of people ...

A substantial proportion of patients with type 2 diabetes experienced micronutrient deficiency, particularly vitamin D deficiency, a meta-analysis of more than 50,000 participants revealed.

A thorough examination of modern drugs that target particular receptors and metabolic pathways for glucose and fat metabolism is presented. Recent research has revealed innovative targets and ...

A recent study from Karolinska Institutet suggests that a type of diabetes medication called GLP-1 agonists could reduce the ...

The FDA has approved popular antiobesity drug Ozempic to help protect patients with type 2 diabetes from kidney disease.

More than 45 percent of patients with type 2 diabetes (T2D) have micronutrient deficiencies, with the most prevalent ...

Results from a case series identified a potential association between ophthalmic complications and the rapid correction of hyperglycemia, brought on by patients using either semaglutide or tirzepatide ...

Surgical patients may still have leftovers in their system even after a standard fast, potentially increasing the chance of a serious complication.

Participants with metabolic syndrome who received 1,700 mg metformin daily with or without a Mediterranean diet intervention ...

A lack of essential micronutrients, such as vitamin D and magnesium, as well as a few others, may be behind 'hidden hunger' ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...